Medscape

Generic DPP-4 Inhibitors Would Be a 'Shot in the Arm'

In September, Indian drug manufacturer Alembic received a tentative nod from the US Food and Drug Administration (FDA) to manufacture generic alogliptin as well as the alogliptin/metformin fixed-drug ...
Medscape

SGLT2 Inhibitor Top DPP-4 Inhibitor for Survival in Diabetic Kidney Disease

SGLT2 inhibitors showed significantly improved mortality benefits compared with DPP-4 inhibitors in patients with diabetic kidney disease (DKD) in a large target trial emulation study that adds ...
Monthly Prescribing Reference

Depression Risk Lower With GLP-1 Receptor Agonists vs DPP-4 Inhibitors in Seniors

Researchers found that the rate difference of depression was 3.48 per 1000 person-years between GLP-1 RA users and SGLT-2i users. HealthDay News — For older adults with type 2 diabetes (T2D), use of ...
MedPage Today

SGLT-2 Inhibitors Top Other Diabetes Medications for Eye Safety

STOCKHOLM -- The sodium glucose co-transporter 2 (SGLT2) class of diabetes medications may offer more protection against diabetic retinopathy as compared with other hypoglycemic agents, an analysis of ...
The American Journal of Managed Care

Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor. Results: Initially, more than 50% of ...
BioWorld

Items Tagged with 'GPR119/DPP-4 dual inhibitors'

Among the emerging therapeutic strategies for type 2 diabetes (T2D), G protein-coupled receptor 119 (GPR119) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated promise due to ...
Medical Dialogues

SGLT2 Inhibitors tied to Superior Cardiorenal and Hepatic Outcomes in Diabetes patients With Cirrhosis: JAMA

A recent study published in the Journal of the American Medical Association revealed that the use of sodium-glucose ...
BioWorld

Dual targeting of GPR119 and DPP-4 improves T2DM treatment

Among the emerging therapeutic strategies for type 2 diabetes (T2D), G protein-coupled receptor 119 (GPR119) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors have demonstrated promise due to ...
MedPage Today

Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SGLT2 inhibitors ...
Healio

SGLT2 inhibitors benefit patients with type 2 diabetes, regardless of glycemic control

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data derived from: D ...
Renal & Urology News

Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors

Modestly lower risk for depression seen compared with DPP-4i use, but not compared with SGLT-2i use. (HealthDay News) — For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 ...